2Lai KN, Tang SC, Guh JY. et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growthactor - beta synthesis and signal transduction in human mesangial cells via the enin - angio- tensin system [ J ]. Am Soc Nephrol,2003,14 ( 12 ) :3127 - 3137.
3Border WA, Noble NA, Ketteler M. TGF - β : acytokine mediator of glomerulosclerosis and a target for therapeutic intervention [ J ]. Kid- ney Int, 1995,47 ( Suppl 49) :59 - 61.
4Lim CS, Kim YS, Chae DW, et al. Association of C -509 T and T869Cpolymorphisms of transforming growth factor beta - gene with susceptibilityto and progression of IgA nephropathy[ J]. Clin Nephrol, 2005,63(2) :61 -67.
5Munger JS, Harpel JG, Gleizes PE, et al. Latent transforming growth factor-beta : structural features and mechanisms of activation [ J ]. Kidney Int, 1997,51 (5) : 1376-1382.
6Shankland SJ, Pippin J, Pichler RH, et al. Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy [ J]. Kidney Int, 1996,50 ( 1 ) : 116-124.
7Kretzschmar M, Massague J. SMADs: mediators and regulators of TGF-beta signaling [ J]. Curr Opin Genet Dev, 1998,8 ( 1 ) : 103-111.
8Schiller B,Moran J. Experimental glomerulosclerosis:defektheilung of the kidney[ J]. Artif Organs, 1996,20 (5) :445-450.
9Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy [ J ]. Kidney Int, 1997,51 ( 5 ) : 1388-1396.
10Murakami K, Takemura T, Hino S, et al. Urinary transforming growth factor -beta in patients with glomerular diseases[ J]. Pediatr Nephrol, 1997,11 ( 3 ) : 334-336.
